CSIMarket



Stryker Corp  (SYK)
Other Ticker:  
 
 

SYK's Capital Expenditures Growth by Quarter and Year

Stryker's Capital Expenditures results by quarter and year




SYK Capital Expenditures (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 206.00 165.00 199.00
III Quarter September - 130.00 69.00 163.00
II Quarter June - 106.00 109.00 165.00
I Quarter March 119.00 83.00 144.00 122.00
FY   119.00 525.00 487.00 649.00



SYK Capital Expenditures first quarter 2022 Y/Y Growth Comment
Stryker Corp achieved in the first quarter 2022, above Company average Capital Expenditures rise of 43.37% year on year, to $ 119.00 millions.

Looking into first quarter 2022 results within Medical Equipment & Supplies industry 9 other companies have achieved higher Capital Expenditures growth. While Stryker Corp' s Capital Expenditures jump of 43.37% ranks overall at the positon no. 236 in the first quarter 2022.




SYK Capital Expenditures ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 24.85 % -17.09 % 29.22 %
III Quarter September - 88.41 % -57.67 % -45.12 %
II Quarter June - -2.75 % -33.94 % 5.1 %
I Quarter March 43.37 % -42.36 % 18.03 % 0.83 %
FY   - 7.8 % -24.96 % -10.97 %

Financial Statements
Stryker's first quarter 2022 Capital Expenditures $ 119.00 millions SYK's Income Statement
Stryker's first quarter 2021 Capital Expenditures $ 83.00 millions Quarterly SYK's Income Statement
New: More SYK's historic Capital Expenditures Growth >>


SYK Capital Expenditures (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 58.46 % 139.13 % 22.09 %
III Quarter September - 22.64 % -36.7 % -1.21 %
II Quarter June - 27.71 % -24.31 % 35.25 %
I Quarter March -42.23 % -49.7 % -27.64 % -20.78 %
FY (Year on Year)   - 7.8 % -24.96 % -10.97 %




Capital Expenditures first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #10
Healthcare Sector #24
Overall #236

Capital Expenditures Y/Y Growth Statistics
High Average Low
119.61 % 7.67 % -32.22 %
(Dec. 31. 2009)   (June 30. 2016)
Capital Expenditures first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #10
Healthcare Sector #24
Overall #236
Capital Expenditures Y/Y Growth Statistics
High Average Low
119.61 % 7.67 % -32.22 %
(Dec. 31. 2009)   (June 30. 2016)

Capital Expenditures by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Stryker's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
139.13 % 11.51 % -100 %
(Dec 31 2020)  


SYK's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2022 Stryker Corp realized fall in Capital Expenditures from the forth quarter by -42.23% to $ 119.00 millions, from $ 206.00 millions achived in the previous reporting period.

When you look into recent downturn at the I. Quarter, you must presume, that commonly I. Quarter Capital Expenditures appear to be weaker relative to the preciding period

Within Medical Equipment & Supplies industry 15 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Stryker's Capital Expenditures growth quarter on quarter, overall rank is 406.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #16
Healthcare Sector #43
Overall #406
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #16
Healthcare Sector #43
Overall #406
Capital Expenditures Q/Q Growth Statistics
High Average Low
139.13 % 11.51 % -100 %
(Dec 31 2020)  


SYK's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2022 Stryker Corp reported fall in Capital Expenditures from the previous quarter by -42.23% to $ 119.00 millions, from $ 206.00 millions declared in the previous quarter.

If you look into current downturn in the quarter, you should take into consideration, that usually I. Quarter performance appear to be softer then in the quarter before, Donnalyn Gómez, Medical Equipment & Supplies industry observer situated in Madrid added.

Within Medical Equipment & Supplies industry 15 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Stryker's Capital Expenditures growth quarter on quarter, overall rank is 406.


Stryker's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Capital Expenditures 12 Months Ending $ 561.00 $ 525.00 $ 484.00 $ 423.00 $ 426.00
Y / Y Capital Expenditures Growth (TTM) 31.69 % 7.8 % -7.1 % -31.22 % -36.51 %
Year on Year Capital Expenditures Growth Overall Ranking # 235 # 303 # 1660 # 2069 # 2095
Seqeuential Capital Expenditures Change (TTM) 6.86 % 8.47 % 14.42 % -0.7 % -12.53 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 236 # 1312 # 1053 # 1984 # 2167




Cumulative Capital Expenditures growth Comment
Stryker saw improvement in Capital Expenditures growth trend, posting cumulative 12 months Capital Expenditures growth of 31.69% year on year, to $ 561 millions if the fiscal year would have ended in Mar 31 2022.
Stryker's trailing twelve months Capital Expenditures growth was higher than company's average 25.5% and higher than 7.8% growth in Dec 31 2021.
But from the previous reporting period increase was slower at 6.86 % from $525 millions achieved in twelve months ending a quarter Dec 31 2021 Donnalyn Gómez added on.
We witness drop-off developing, more obvious observing the If you usual sequential historic advancement that is stronger at7.67% Donnalyn Gómez noted.
The growth is even higher from the previous reporting period exhibited at 6.86 % jump from $525 millions in twelve months ending a quarter Dec 31 2021.

Within the Healthcare sector 21 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 235, from total ranking in previous quarter at 303.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
119.61 %
7.67 %
-32.22 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 10
Healthcare Sector # 22
Overall # 235

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
190.16 %
25.5 %
-36.51 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 24
S&P 500 # 236
Cumulative Capital Expenditures growth Comment
Stryker saw improvement in Capital Expenditures growth trend, posting cumulative 12 months Capital Expenditures growth of 31.69% year on year, to $ 561 millions if the fiscal year would have ended in Mar 31 2022.
Stryker's trailing twelve months Capital Expenditures growth was higher than company's average 25.5% and higher than 7.8% growth in Dec 31 2021.
But from twelve months ended Dec 31 2021 rise was beneth at 6.86 % from $525 millions reported in twelve months ending a quarter Dec 31 2021.
There is stagnation happening, more noticeable as we look at If you usual Q/Q TTM Capital Expenditures rise which is higher at 7.67%.
The growth is even stronger sequentially clinched at 6.86 % jump from $525 millions in twelve months ending a quarter before.

Within the Healthcare sector 21 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 235, from total ranking in previous quarter at 303.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
119.61 %
7.67 %
-32.22 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 10
Healthcare Sector # 22
Overall # 235

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
190.16 %
25.5 %
-36.51 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 24
S&P 500 # 236




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
SYK's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for SYK's Competitors
Capital Expenditures Growth for Stryker's Suppliers
Capital Expenditures Growth for SYK's Customers

You may also want to know
SYK's Annual Growth Rates SYK's Profitability Ratios SYK's Asset Turnover Ratio SYK's Dividend Growth
SYK's Roe SYK's Valuation Ratios SYK's Financial Strength Ratios SYK's Dividend Payout Ratio
SYK's Roa SYK's Inventory Turnover Ratio SYK's Growth Rates SYK's Dividend Comparisons



Companies with similar Capital Expenditures fall for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2022
Actinium Pharmaceuticals Inc 75.00%$ 75.000 millions
Ocular Therapeutix Inc 74.68%$ 74.684 millions
Tivity Health Inc 73.93%$ 73.927 millions
Axogen inc 72.78%$ 72.778 millions
Clearpoint Neuro Inc 72.50%$ 72.500 millions
Vor Biopharma Inc 71.73%$ 71.734 millions
Option Care Health Inc 71.60%$ 71.598 millions
Nkarta Inc 71.35%$ 71.346 millions
Passage Bio inc.71.02%$ 71.022 millions
Sotera Health Company69.74%$ 69.735 millions
Neurocrine Biosciences Inc 68.89%$ 68.889 millions
Aligos Therapeutics Inc 67.75%$ 67.752 millions
Organon and Co 65.79%$ 65.789 millions
Healthcare Services Group Inc 65.53%$ 65.529 millions
Owens and Minor Inc 65.50%$ 65.499 millions
Icu Medical Inc63.46%$ 63.457 millions
Athersys Inc63.16%$ 63.158 millions
Intuitive Surgical Inc 62.29%$ 62.287 millions
Avantor Inc 62.25%$ 62.252 millions
Axon Enterprise inc 62.23%$ 62.233 millions
Hims and Hers Health Inc 61.52%$ 61.519 millions
Boston Scientific Corporation61.33%$ 61.333 millions
Outset Medical Inc 60.83%$ 60.827 millions
Neuronetics Inc 59.11%$ 59.111 millions
Kura Oncology Inc 58.06%$ 58.065 millions
U S Physical Therapy Inc57.21%$ 57.214 millions
Harvard Bioscience Inc56.48%$ 56.478 millions
Poseida Therapeutics Inc 56.42%$ 56.421 millions
Precigen Inc 55.72%$ 55.720 millions
Decibel Therapeutics Inc 55.38%$ 55.385 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BEP's Profile

Stock Price

BEP's Financials

Business Description

Fundamentals

Charts & Quotes

BEP's News

Suppliers

BEP's Competitors

Customers & Markets

Economic Indicators

BEP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071